Ironwood Pharmaceuticals
IRWD
IRWD
239 hedge funds and large institutions have $2.02B invested in Ironwood Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 56 funds opening new positions, 76 increasing their positions, 78 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
239
Holders Change
+18
Holders Change %
+8.14%
% of All Funds
4.04%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
56
Increased
76
Reduced
78
Closed
31
Calls
$876K
Puts
$231K
Net Calls
+$645K
Net Calls Change
+$1.14M
Top Buyers
| 1 |
BlackRock
New York
|
$310M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$39.7M |
| 3 |
State Street
Boston,
Massachusetts
|
$126M |
| 4 |
Renaissance Technologies
New York
|
$62.4M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
$167M |
Top Sellers
| 1 |
Westfield Capital Management
Boston,
Massachusetts
|
$26.7M |
| 2 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
$134M |
| 3 |
Goldman Sachs
New York
|
$11.4M |
| 4 |
Norges Bank
Oslo,
Norway
|
$16.6M |
| 5 |
Citadel Advisors
Miami,
Florida
|
$0 |
